Skip to content

Key points

  • Vaccines mimic a first encounter with an infection, so the body’s defences are trained to recognise and combat the real infection.
  • After immunisation some long-lived memory cells remember the invader and wake up when it’s back, ensuring long-lasting protection.
  • PrEP is not a vaccine: it protects against HIV only when the drug is present in the body.

A vaccine is, essentially, a fake infection.

Edward Jenner discovered in 1757 that if you gave people cowpox, they didn’t get smallpox. Even before then it had been known in some cultures that a mild form of a disease could protect people from a severe form. This is because if people have a mild infection – or are given a substance that is not an infection but looks like one to the immune system – then the immune system will remember it.

This remarkable ability of our immune system protects us from repeated severe illnesses that would otherwise eventually kill us.

Once the B-cells and T-cells that are the body’s disease fighters have reacted to an infection and helped to expel it from the body, then most die. But a small proportion of long-lived memory cells withdraw deep into the immune system’s centres in the bone marrow and lymph nodes. They are primed to wake up and start reproducing in huge numbers as soon as the infection they remember, or something that looks like it, comes along.

To use an analogy: if the body is a nightclub, the immune system is the security team. A vaccine is like a photo ID of a drug dealer, circulated to the security team. Then, if the real person ever turns up, they are either refused entry, or, if they manage to get in, apprehended and expelled. (HIV, however, is a master of disguise, and can subvert the security team.)

Is PrEP a vaccine?

Sometimes other ways of preventing HIV are spoken of as if they were a vaccine. This is particularly the case with pre-exposure prophylaxis (PrEP). It’s a medicine, and it stops you getting HIV – so isn’t it a sort of vaccine?

The difference between a vaccine and PrEP is that a vaccine, because it mobilises our body’s own defences, may only have to be renewed occasionally or, in the case of childhood vaccines for things like polio or measles, never.

But PrEP stops working when you stop taking it.

In the near future, long-lasting formulations of HIV drugs will be available that may only have to be given once or twice a year as both treatment and PrEP – and then as injections or implants, so they may feel like a vaccine.

The power of a vaccine, however, lies in the fact that it strengthens your body’s own defences against viruses and bacteria, instead of simply killing or inactivating them with a drug.

Getting it to do this, though, especially with a foe as tricky as HIV, is not straightforward, and has already had to involve some groundbreaking science.

Gus Cairns

Gus Cairns

Editorial Consultant

Gus joined aidsmap's editorial team in 2009 and previously edited HIV Treatment Update and Preventing HIV. He retired from full-time work in 2023 and now contributes news and conference reports as a freelancer. He is also co-chair for Combination Prevention at the European AIDS Treatment Group. LinkedIn  |  Facebook

Photo: Steven Doyle

Basic information

Myths and facts

Myths and facts

What is an elite controller?

What’s the latest news on HIV vaccines?

CDC/Unsplash

Why is it so difficult to make an HIV prevention vaccine?

Marco Verch. Creative Commons licence.

Why have we got COVID vaccines but not HIV vaccines?

CDC/Unsplash

Could an mRNA vaccine protect against HIV?

Mufid Majnun/Unsplash

The search for an HIV prevention vaccine

Image: Adam Gregor/Shutterstock.com

Why is HIV hard to cure?

Liya Graphics/Shutterstock.com

HIV cure

HIV cure

Ethics in cure research

Mareike Günsche | www.aspect-us.com

Diversity and equity in HIV cure research

Mareike Günsche | www.aspect-us.com

Should HIV controllers take HIV treatment?

A doctor and patient talking in a doctor's office.

Clinical trials

Chinnapong/Shutterstock.com

Thinking about joining a clinical trial?

Mareike Günsche | www.aspect-us.com

HIV-1 subtypes

Image: Kateryna Kon/Shutterstock.com

HIV-1 and HIV-2

Illustration of purple HIV viruses on a white background.

Cases of HIV cure

Image from Timothy Ray Brown's interview with German magazine Stern in 2010.

The search for an HIV cure

Kateryna Kon/Shutterstock.com

Phases of clinical trials

A doctor wearing a light brown shirt and a stethoscope around his neck sitting at a desk and talking to a patient who's wearing a purple t-shirt.